JP2025506019A5 - - Google Patents

Info

Publication number
JP2025506019A5
JP2025506019A5 JP2024547152A JP2024547152A JP2025506019A5 JP 2025506019 A5 JP2025506019 A5 JP 2025506019A5 JP 2024547152 A JP2024547152 A JP 2024547152A JP 2024547152 A JP2024547152 A JP 2024547152A JP 2025506019 A5 JP2025506019 A5 JP 2025506019A5
Authority
JP
Japan
Prior art keywords
pharmaceutical
administration
pharmaceutical composition
pharmaceutically acceptable
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506019A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062136 external-priority patent/WO2023154705A1/en
Publication of JP2025506019A publication Critical patent/JP2025506019A/ja
Publication of JP2025506019A5 publication Critical patent/JP2025506019A5/ja
Pending legal-status Critical Current

Links

JP2024547152A 2022-02-08 2023-02-07 トレプロスチニルイロプロスト併用療法 Pending JP2025506019A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307919P 2022-02-08 2022-02-08
US63/307,919 2022-02-08
PCT/US2023/062136 WO2023154705A1 (en) 2022-02-08 2023-02-07 Treprostinil iloprost combination therapy

Publications (2)

Publication Number Publication Date
JP2025506019A JP2025506019A (ja) 2025-03-05
JP2025506019A5 true JP2025506019A5 (cg-RX-API-DMAC7.html) 2026-02-05

Family

ID=85510816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547152A Pending JP2025506019A (ja) 2022-02-08 2023-02-07 トレプロスチニルイロプロスト併用療法

Country Status (9)

Country Link
US (1) US20230263807A1 (cg-RX-API-DMAC7.html)
EP (1) EP4475819A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506019A (cg-RX-API-DMAC7.html)
KR (1) KR20240141319A (cg-RX-API-DMAC7.html)
CN (1) CN118984697B (cg-RX-API-DMAC7.html)
AU (1) AU2023219692A1 (cg-RX-API-DMAC7.html)
CA (1) CA3243453A1 (cg-RX-API-DMAC7.html)
IL (1) IL314791A (cg-RX-API-DMAC7.html)
WO (1) WO2023154705A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260166056A1 (en) * 2024-12-13 2026-06-18 United Therapeutics Corporation Treprostinil formulations and their uses

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2485614A (en) 1946-08-29 1949-10-25 Chicago Bridge & Iron Co Stabilizing and guide apparatus for lifter roofs
US3037116A (en) 1957-07-26 1962-05-29 Weber Georges Apparatus for irradiating liquids
US3035516A (en) 1958-08-18 1962-05-22 Lee Brothers Company Stencil device
US3646509A (en) 1969-08-08 1972-02-29 Texas Instruments Inc Method for field stacking seismic data and system using write after read bulk data storage
US4306075A (en) 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4547016A (en) 1984-08-13 1985-10-15 Eeco Incorporated Quick release mounting
GB8814438D0 (en) 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
IT1231076B (it) 1989-09-28 1991-11-12 Pirelli Cavi Spa Procedimento per la realizzazione di gruppo di connessione separabile per fibre ottiche riunite a nastro e gruppo di connessione con esso realizzato.
GB9011588D0 (en) 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
ES2214753T3 (es) 1997-11-14 2004-09-16 United Therapeutics Corporation Uso de 9-desoxi-2',9-alfa-metano-3-oxa-4,5,6-trinor-3,7-(1',3'-interfenilen)-13,14-dihidro-prostaglandina f1 para tratar la enfermedad vascular periferica.
US6521212B1 (en) 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
KR20020012169A (ko) 1999-03-31 2002-02-15 유나이티드 쎄러퓨틱스 코포레이션 프로스타글란딘 화합물, 조성물 및 말초혈관질병 및폐고혈압증의 치료방법
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US7305986B1 (en) 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6803386B2 (en) 2002-01-16 2004-10-12 United Therapeutics Corporation Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
US6756117B1 (en) 2002-12-20 2004-06-29 The United States Of America As Represented By The United States Department Of Energy Photonic polymer-blend structures and method for making
CN102697790A (zh) 2003-05-22 2012-10-03 联合治疗公司 化合物和释放前列环素类似物的方法
CN1917866B (zh) 2003-12-16 2010-12-15 联合治疗公司 曲前列环素或它的衍生物,或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途
US7199157B2 (en) 2003-12-16 2007-04-03 United Therapeutics Corporation Use of treprostinil to improve kidney functions
DE602005020269D1 (de) 2004-04-12 2010-05-12 United Therapeutics Corp Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
CA2574958A1 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
CA2654492C (en) 2006-05-15 2017-06-27 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler
CN103181893A (zh) 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
WO2009078965A1 (en) 2007-12-17 2009-06-25 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin
JP6219016B2 (ja) 2008-05-08 2017-10-25 ユナイテッド セラピューティクス コーポレーション トレプロスチニル一水和物
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
CN102421288B (zh) 2009-05-07 2015-04-22 联合治疗公司 前列环素类似物的固体剂型
KR20160132501A (ko) 2010-03-15 2016-11-18 유나이티드 세러퓨틱스 코오포레이션 폐고혈압의 치료
US20130040898A1 (en) * 2010-04-29 2013-02-14 Pär Johansson Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
CN103261142B (zh) 2010-06-03 2014-12-10 联合治疗公司 曲前列环素的制备
CA2710725C (en) 2010-07-22 2017-08-01 Alphora Research Inc. Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation
ES2581762T3 (es) 2011-03-02 2016-09-07 United Therapeutics Corporation Síntesis de producto intermedio para la producción de treprostinil
US9388154B2 (en) 2011-09-12 2016-07-12 Lund Biotechnology PBC Process for preparing synthetic prostacyclins
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
SI2674413T1 (sl) 2012-06-15 2017-10-30 Scipharm Sarl Postopek za pripravo treprostinila in derivatov le-tega
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
CA2911172C (en) 2013-04-30 2021-10-19 United Therapeutics Corporation Controlled release pharmaceutical formulations
US9469600B2 (en) 2013-10-25 2016-10-18 Insmed Incorporated Prostacyclin compounds, compositions and methods of use thereof
JP2016538161A (ja) 2013-11-27 2016-12-08 コーニング インコーポレイテッド 基板の改善された製造のための組成
WO2015138423A1 (en) * 2014-03-11 2015-09-17 Insmed Incorporated Prostacylin compositions and methods for using the same
WO2015174197A1 (ja) 2014-05-14 2015-11-19 富士電機株式会社 半導体装置および半導体装置の製造方法
WO2016038532A1 (en) 2014-09-09 2016-03-17 Mylan Laboratories Limited Amorphous treprostinil diethanolamine
HU231184B1 (hu) 2014-10-08 2021-07-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Treprostinil-nátrium-monohidrát és eljárás ennek előállítására
CN107108427A (zh) 2014-10-20 2017-08-29 联合治疗学有限公司 用于制备前列环素衍生物的中间体的合成
US10343979B2 (en) 2014-11-18 2019-07-09 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
WO2016105538A1 (en) 2014-12-23 2016-06-30 Sandia Corporation Sandia National Laboratories Adjusting the ph of a pretreatment solution using carbon dioxide useful for integrating saccharification and fermentation
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
KR20180133401A (ko) 2016-04-08 2018-12-14 이데미쓰 고산 가부시키가이샤 전기 화학 소자용 바인더
EP3452170A4 (en) * 2016-05-05 2020-04-01 Liquidia Technologies, Inc. TREPROSTINIL IN POWDER FORM FOR TREATING PULMONAL HYPERTENSION
WO2018058124A1 (en) 2016-09-26 2018-03-29 United Therapeutics Corporation Treprostinil prodrugs
IL266518B2 (en) * 2016-11-10 2026-05-01 Arena Pharm Inc Methods for treating pulmonary hypertension with combinations of relinfag and other substances
CA3102967A1 (en) 2018-06-07 2019-12-12 Mannkind Corporation Composition and method for inhalation
CN114616225A (zh) 2019-08-23 2022-06-10 联合治疗公司 曲前列环素前药
IL296567A (en) 2020-04-17 2022-11-01 United Therapeutics Corp Terfostinil for use in the treatment of interstitial lung disease
AU2021289336B2 (en) 2020-06-09 2025-08-28 Mannkind Corporation Fumaryl diketopiperidine prodrugs of treprostinil

Similar Documents

Publication Publication Date Title
JP7621220B2 (ja) 疾患の処置のための鼻腔内エピネフリン製剤及び方法
Graham et al. No added benefit from nebulized amiloride in patients with cystic fibrosis
JP2024095678A5 (cg-RX-API-DMAC7.html)
US20010041190A1 (en) Method for pulmonary and oral delivery of pharmaceuticals
JP2019528320A5 (cg-RX-API-DMAC7.html)
KR102733397B1 (ko) 비강내 에피네프린 제제 및 질환의 치료 방법
JP2022137070A5 (cg-RX-API-DMAC7.html)
EP3801552A1 (en) Composition and method for inhalation
RU2685706C2 (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
JP2023523557A5 (cg-RX-API-DMAC7.html)
US20190321290A1 (en) Composition and method for inhalation
UA119774C2 (uk) Комбінації формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл)
KR20030031997A (ko) 살메테롤과 플루티카손 프로피오네이트의 약제학적포뮬레이션
CN116635018A (zh) 吸入用药物组合物
KR20230005937A (ko) 바이러스 감염의 치료 또는 예방을 위한 클로파지민 조성물 및 방법
Shah et al. An evaluation of two aerosol delivery systems for rhDNase
JPH10500966A (ja) 経口吸入もしくは吹き込みにより投与する為の化合物、及び組成物
JP2025506019A (ja) トレプロスチニルイロプロスト併用療法
JP2024520912A5 (cg-RX-API-DMAC7.html)
CN107137518A (zh) 一种止喘灵雾化吸入用溶液制剂及其制备方法
EP4051307B1 (en) Peptide for prevention or treatment of covid-19
CN121487728A (zh) 喷雾干燥的曲前列环素制剂
HK40083799A (en) Clofazimine composition and method for the treatment or prophylaxis of viral infections
Terzano et al. Corticosteroids administered by nebulization to children with bronchial asthma
RU2326670C1 (ru) Способ комплексной интенсивной терапии острого стенозирующего ларинготрахеита у детей